Glaucoma

hongchiong 2,250 views 47 slides Aug 18, 2014
Slide 1
Slide 1 of 47
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47

About This Presentation

Glaucoma. A lecture from Dr. Lee from Penang Medical College


Slide Content

GlaucomaGlaucoma
Dr Lee Ming YuehDr Lee Ming Yueh
Ophthalmology UnitOphthalmology Unit
Penang HospitalPenang Hospital

Glaucoma is a sight threatening disease Glaucoma is a sight threatening disease
which can cause irreversible visual losswhich can cause irreversible visual loss
Baltimore Eye Survey:Baltimore Eye Survey:
- - by the year 2000 by the year 2000 > 66.8 million primary glaucoma > 66.8 million primary glaucoma
> 6.7 million bilateral blindness > 6.7 million bilateral blindness

DefinitionDefinition
A spectrum of disease characterized byA spectrum of disease characterized by
- progressive optic neuropathy- progressive optic neuropathy
- visual field loss- visual field loss
**IOP is an important risk factor. IOP is an important risk factor.

Optic NeuropathyOptic Neuropathy

Progression of
Glaucomatous
Optic Neuropathy

Visual Field Visual Field
LossLoss

Classification:Classification:
Open Angle GlaucomaOpen Angle Glaucoma
Close Angle GlaucomaClose Angle Glaucoma
Congenital GlaucomaCongenital Glaucoma

Trabecular meshwork acts like a sieve…Trabecular meshwork acts like a sieve…

Angle StructureAngle Structure

Open Angle GlaucomaOpen Angle Glaucoma
PrimaryPrimary
Risk factors :Risk factors :Age > 60Age > 60
Race – negro, darkRace – negro, dark
Family history – siblings 4xFamily history – siblings 4x
- parents 2x- parents 2x
Ocular ds – myopia, Retinitis PigmentosaOcular ds – myopia, Retinitis Pigmentosa
Cardiovascular ds, DM, SAS, migraine ?Cardiovascular ds, DM, SAS, migraine ?
SecondarySecondary
a.a.Pretrabecular – neovascular/inflammatory membranePretrabecular – neovascular/inflammatory membrane
b. b. Trabecular- RBC, pseudoexfoliation, pigmentTrabecular- RBC, pseudoexfoliation, pigment
c.c.Post Trabecular- TED, Carotid-cavernous fistulaPost Trabecular- TED, Carotid-cavernous fistula

Primary Open Angle GlaucomaPrimary Open Angle Glaucoma

Traumatic Hyphaema with Traumatic Hyphaema with
secondary open angle glaucomasecondary open angle glaucoma

Pseudoexfoliative SyndromePseudoexfoliative Syndrome

Open Angle GlaucomaOpen Angle Glaucoma
Clinical features:Clinical features:
- ‘silent thief of sight’- ‘silent thief of sight’
- Painless gradual loss of vision; loss of - Painless gradual loss of vision; loss of
visual field follows by impairment of visual visual field follows by impairment of visual
acuity.acuity.
- Intraocular pressure (IOP) rise gradually, - Intraocular pressure (IOP) rise gradually,
usually asymptomatic, till significant visual usually asymptomatic, till significant visual
impairment occurs.impairment occurs.

This is what a glaucoma patient This is what a glaucoma patient
sees….sees….

ExaminationExamination
1.1.Visual acuityVisual acuity
2.2.Pupil – afferent pupillary defectPupil – afferent pupillary defect
3.3.Intra-ocular Pressure (IOP)Intra-ocular Pressure (IOP)
- IOP > 21 mmHg- IOP > 21 mmHg
- IOP asymmetry > 3 mmHg- IOP asymmetry > 3 mmHg

4.4.Optic nerve head & retinal nerve fibre layer Optic nerve head & retinal nerve fibre layer
assessmentassessment
- vertical cup-disc ratio (CDR) > 0.7- vertical cup-disc ratio (CDR) > 0.7
- Asymmetry of CDR > 0.2- Asymmetry of CDR > 0.2
- thinning & notching of neuroretinal rim, - thinning & notching of neuroretinal rim,
nasalization & bayonetting of retinal vessels.. nasalization & bayonetting of retinal vessels..
(Normal NRR follow ‘ISNT rule’).(Normal NRR follow ‘ISNT rule’).
- Laminar dots sign- Laminar dots sign
- optic disc haemorrhage- optic disc haemorrhage

5. Evaluation of the angle5. Evaluation of the angle
GonioscopyGonioscopy
- open or close ?- open or close ?
- to exclude secondary cause of glaucoma- to exclude secondary cause of glaucoma

Angle StructureAngle Structure

Grading for Gonioscopy findingGrading for Gonioscopy finding
GradeGrade00 II IIII IIIIII IVIV
ShafferShafferclosedclosed1010°° 2020°° 3030°° 4040°°
ModifieModifie
ShafferShaffer
Schwalbe Schwalbe
lineline
Not seenNot seen
SchwalbeSchwalbe
Line Line
visiblevisible
TrabTrab
MeshworkMeshwork
visiblevisible
Scleral Scleral
spurspur
visiblevisible
Ciliary Ciliary
Body Body
visiblevisible

Shaffer Gonioscopic ClassificationShaffer Gonioscopic Classification

Eclipse SignEclipse Sign

6.6.Visual Field TestVisual Field Test
- Humphrey visual field is gold standard- Humphrey visual field is gold standard
- classical VF defects are - classical VF defects are
: : paracentral scotomaparacentral scotoma
nasal stepnasal step
Arcuate scotomaArcuate scotoma
Temporal wedgeTemporal wedge

Humprey Humprey
Visual FieldVisual Field

Optic disc photographOptic disc photograph showing thinning of the inferior showing thinning of the inferior
neuroretinal rim and increased cupping, consistent with neuroretinal rim and increased cupping, consistent with
glaucoma.glaucoma.
Humphrey visual fieldHumphrey visual field showing showing superior arcuatesuperior arcuate defect defect
and and nasal stepnasal step corresponding to the glaucomatous optic corresponding to the glaucomatous optic
nerve changes on the left.nerve changes on the left.

Management:Management:
MedicalMedical
topical anti-glaucoma topical anti-glaucoma
- B-blocker eg Timolol, Betoptic- B-blocker eg Timolol, Betoptic
- prostaglandin analog - prostaglandin analog
- carbonic anhydrace inhibitor- carbonic anhydrace inhibitor
- - αα agonist agonist
Laser TreatmentLaser Treatment
- Argon laser trabeculoplasty /Selective LT- Argon laser trabeculoplasty /Selective LT
SurgicalSurgical
- Trabeculectomy/augmented trabeculectomy- Trabeculectomy/augmented trabeculectomy
- Shunt/valve surgery- Shunt/valve surgery
ConservativeConservative
- asymptomatic poor visual prognosis- asymptomatic poor visual prognosis

Indications for surgery:Indications for surgery:
1.1.Failed medical therapyFailed medical therapy
2.2.Disease progression despite maximun Disease progression despite maximun
medical therapymedical therapy
3.3.Anticipated fast progressionAnticipated fast progression
4.4.Combined cataract & trabeculectomy Combined cataract & trabeculectomy
surgerysurgery

Primary Angle Closure GlaucomaPrimary Angle Closure Glaucoma
Risk Factors:Risk Factors:
- - age, average 60 y-oldage, average 60 y-old
- female more common 4:1- female more common 4:1
- race: more common in SEA, Chinese, - race: more common in SEA, Chinese,
Eskimos.Eskimos.
- Family: 1- Family: 1
stst
degree relatives increased risk . degree relatives increased risk .

Anatomical predisposing factorsAnatomical predisposing factors
1.1.Relatively anterior location of iris-lens Relatively anterior location of iris-lens
diaphragm.diaphragm.
2.2.Shallow anterior chamberShallow anterior chamber
3.3.Narrow entrance to the chamber angleNarrow entrance to the chamber angle
Eyes with PACGEyes with PACG have have
-corneal diameter 0.25mm smaller than normal -corneal diameter 0.25mm smaller than normal
eyeseyes
- shallower anterior chamber (1.8mm)- shallower anterior chamber (1.8mm)
- hypermetropic eyes- hypermetropic eyes

Secondary- Pupillary Block GlaucomaSecondary- Pupillary Block Glaucoma
Inflammatory with occlusio or seclusio Inflammatory with occlusio or seclusio
pupillaepupillae
PhacomorphicPhacomorphic
Vitreous blocVitreous bloc
Silicone oilSilicone oil

Secondary-NonPupillary Block Secondary-NonPupillary Block
GlaucomaGlaucoma
NeovascularNeovascular
Iridocorneal endothelial syndromIridocorneal endothelial syndrom
Ciliary tumour, iris cystCiliary tumour, iris cyst
Suprachoroidal haemorrhageSuprachoroidal haemorrhage
Iatrogenic- tight scleral buckling, post PRPIatrogenic- tight scleral buckling, post PRP

Clinical Features:Clinical Features:
Rapidly progressive blurring of visionRapidly progressive blurring of vision
Periocular pain and congestionPeriocular pain and congestion
Nausea and vomiting in severe cases.Nausea and vomiting in severe cases.
Slit-lamp exam:Slit-lamp exam:
- ciliary flush/circumcornea injection- ciliary flush/circumcornea injection
- high IOP (50 -100mmHg)- high IOP (50 -100mmHg)
- cornea oedema w epithelial cysts- cornea oedema w epithelial cysts
- shallow anterior chamber.- shallow anterior chamber.

Acute Management ofAcute Management of
Angle Closure GlaucomaAngle Closure Glaucoma
To lower the IOP fastTo lower the IOP fast
- IV Diamox 500mg /IV Mannitol- IV Diamox 500mg /IV Mannitol
- Topical antiglaucoma- Topical antiglaucoma> pilocarpine 2%> pilocarpine 2%
> timolol 0.5%> timolol 0.5%
> prostaglandin analog > prostaglandin analog
Definitive treatmentDefinitive treatment
- laser peripheral iridectomy/ surgical - laser peripheral iridectomy/ surgical

Further managementFurther management
To To control IOPcontrol IOP to to stop disease progressionstop disease progression
- IOP, optic nerve changes, visual field- IOP, optic nerve changes, visual field
MedicalMedical
- - ββ blocker, prostaglandin analog carbonic blocker, prostaglandin analog carbonic
anhydrace inhibitor, anhydrace inhibitor, αα agonist agonist
SurgicalSurgical
- Trabeculectomy- Trabeculectomy
- Shunt/valve surgery- Shunt/valve surgery

TrabeculotomyTrabeculotomy

Aquoues OutflowAquoues Outflow

Congenital GlaucomaCongenital Glaucoma

Congenital GlaucomaCongenital Glaucoma
Primary Primary
SecondarySecondary
- Anterior segment dysgenesis- Anterior segment dysgenesis
- Ocular ds- Ocular ds
- Phakomatoses eg. Neurofibromatosis- Phakomatoses eg. Neurofibromatosis
- Metabolic ds eg. Lowe’s, Homocysteinuria- Metabolic ds eg. Lowe’s, Homocysteinuria
- Congenital rubella- Congenital rubella
- chromosomal abn eg. Down’s- chromosomal abn eg. Down’s
- Ocular tumour- Ocular tumour
- inflammatory eg. Seronegative arthritis- inflammatory eg. Seronegative arthritis

Clinical Features:Clinical Features:
May manifest at birth or develop laterMay manifest at birth or develop later
Signs & SymptomsSigns & Symptoms

lacrimationlacrimation

PhotophobiaPhotophobia

Hazy corneaHazy cornea

buphthalmosbuphthalmos

rapidly progressive myopiarapidly progressive myopia

BuphthalmosBuphthalmos

Examination under anaesthesiaExamination under anaesthesia
Intraocular pressureIntraocular pressure
Anterior segment examinationAnterior segment examination
- cornea opacity, Haab’s striae- cornea opacity, Haab’s striae
- anterior segment dysgenesis- anterior segment dysgenesis
GonioscopyGonioscopy
- Thicken trabecular meshwork, Barkhan’s - Thicken trabecular meshwork, Barkhan’s
membranemembrane
Fundus examinationFundus examination
- optic cup-disc ratio- optic cup-disc ratio

Management of Congenital GlaucomaManagement of Congenital Glaucoma
Congenital glaucoma is a surgical disease!Congenital glaucoma is a surgical disease!
SurgerySurgery

goniotomy goniotomy

trabeculotomytrabeculotomy

trabeculectomytrabeculectomy
MedicalMedical

topical eye drops ie. topical eye drops ie. ΒΒ-blocker, carbonic anhydrace -blocker, carbonic anhydrace
inhibitor, prostaglandin analoginhibitor, prostaglandin analog

Alfa-2 agonist contraindicated due to sedative effectAlfa-2 agonist contraindicated due to sedative effect

GoniotomyGoniotomy
Barkhan Goniotomy lens & Swan goniotomy knife

Thank YouThank You